Table 2.
Univariate analysis of variables and recurrence
| Test method | Statistics | p value | |
|---|---|---|---|
| Sex | Corrected chi-square test | 0.09 | 0.764 |
| Age | Corrected chi-square test | -1.808 | 0.074 |
| Marital status | Fisher’s exact test | NA | 0.204 |
| Medical insurance | Fisher’s exact test | NA | 0.341 |
| Education | CMH test | 3.818 | 0.051 |
| Chronic pain | Chi-square test | 0.0836 | 0.772 |
| How much do you know about your disease | CMH test | 3.619 | 0.057 |
| Support from the family | CMH test | 0.6633 | 0.415 |
| Burden of medical expenses on the family | CMH test | 0.0155 | 0.901 |
| Hematuria | Chi-square test | 1.7805 | 0.182 |
| Bladder irritation | Corrected chi-square test | 6.82 | 0.009 |
| Dysuria | Corrected chi-square test | 0.25 | 0.617 |
| Initial tumor or recurrent tumor | Chi-square test | 5.2095 | 0.022 |
| Histopathological grade | CMH test | 6.085 | 0.014 |
| Cancer stage | Corrected chi-square test | 4.18 | 0.041 |
| Size of tumor | Chi-square test | 1.4270 | 0.232 |
| Multiplicity | CMH test | 1.405 | 0.236 |
| CIS | Fisher’s exact test | NA | 0.167 |
| AUA risk stratification | CMH test | 9.688 | 0.002 |
| Anxiety symptom | Chi-square test | 4.7998 | 0.028 |
| Depressive symptom | Chi-square test | 11.4019 | 0.001 |
AUA risk stratification: American Urological Association risk stratification for NMIBC. CMH: Cochran-Mantel-Haenszel, CIS: carcinoma in situ, NMIBC: non-muscle invasive bladder cancer